Smoking and asthma: Dangerous liaisons

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 716-725

  Polosa, Riccardo ^a,b   Thomson, Neil C ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Asthma; Smoking; Smoking cessation

Indexed keywords

ATORVASTATIN; AZITHROMYCIN; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOCYTE ELASTASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MACROLIDE; MACROPHAGE ELASTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; SHORT ACTING DRUG; THEOPHYLLINE; TIOTROPIUM BROMIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; HELPER CELL; HUMAN; IMMUNOMODULATION; LOW DRUG DOSE; LUNG FUNCTION; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; SYMPTOMATOLOGY; TH1 CELL; TH17 CELL;

ADRENAL CORTEX HORMONES; ANTIOXIDANTS; ASTHMA; CLINICAL TRIALS AS TOPIC; HUMANS; INFLAMMATION; PHENOTYPE; PROGNOSIS; RESEARCH DESIGN; RISK FACTORS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84875257590     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00073312     Document Type: Review

References (113)

1. World Health Organization report on the global tobacco epidemic, 2008. The MPOWER package. Geneva, World Health Organization, 2008. www.who.int/tobacco/mpower/2008/en/index.html Date last accessed: April 2012.
2. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40-47.
3. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med 2011; 105: 477-484.
4. Cerveri I, Cazzoletti L, Corsico A, et al. The impact of cigarette smoking on asthma: A population-based international cohort study. Int Arch Allergy Immunol 2012; 158: 175-183.
5. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health 2012; 12: 204.
6. Kiviloog J, Irnell L, Eklund G. The prevalence of bronchial asthma and chronic bronchitis in smokers and non-smokers in a representative local Swedish population. Scand J Respir Dis 1974; 55: 262-276.
7. Chen Y, Dales R, Krewski D, et al. Increased effects of smoking and obesity on asthma among female Canadians: The National Population Health Survey, 1994-1995. Am J Epidemiol 1999; 150: 255-262.
8. Langhammer A, Johnsen R, Holmen J, et al. Cigarette smoking gives more respiratory symptoms among women than among men: The Nord-Trondelag Health Study (HUNT). J Epidemiol Community Health 2000; 54: 917-922.
9. Annesi-Maesano I, Oryszczyn MP, Raherison C, et al. Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoke exposure: A cause for concern? Clin Exp Allergy 2004; 34: 1017-1023.
10. Flodin U, Jonsson P, Ziegler J, et al. An epidemiologic study of bronchial asthma and smoking. Epidemiology 1995; 6: 503-505.
11. Toren K, Hermansson BA. Incidence rate of adult-onset asthma in relation to age, sex, atopy, and smoking: A Swedish population-based study of 15,813 adults. Int J Tuberc Lung Dis 1999; 3: 192-197.
12. Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000; 162: 920-924.
13. Chen Y, Dales R, Tang M, et al. Sex-related interactive effect of smoking and household pets on asthma incidence. Eur Respir J 2002; 20: 1162-1166.
14. Piipari R, Jaakkola JJK, Jaakkola N, et al. Smoking and asthma in adults. Eur Respir J 2004; 24: 734-739.
15. Polosa R, Knoke JD, Russo C, et al. Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol 2008; 121: 1428-1434.
16. Thomson NC, Chaudhuri R. Asthma in smokers: Challenges and opportunities. Curr Opin Pulm Med 2009; 15: 39-45.
17. Siroux V, Pin I, Oryszcyn MP, et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J 2000; 15: 470-477.
18. Austin JB, Selvaraj S, Godden D, et al. Deprivation, smoking, and quality of life in asthma. Arch. Dis Child 2005; 90: 253-257.
19. Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 2007; 9: 53-56.
20. Shavit O, Swern A, Dong Q, et al. Impact of smoking on asthma symptoms, healthcare resource use, and quality of life outcomes in adults with persistent asthma. Qual Life Res 2007; 16: 1555-1565.
21. Patel SN, Tsai CL, Boudreaux ED, et al. Multicenter study of cigarette smoking among patients presenting to the emergency department with acute asthma. Ann Allergy Asthma Immunol 2009; 103: 121-127.
22. Mitchell I, Tough SC, Semple LK, et al. Near-fatal asthma: A population-based study of risk factors. Chest 2002; 121: 1407-1413.
23. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1075 outpatients with asthma. Chest 1995; 108: 10-15.
24. Polosa R, Russo C, Caponnetto P, et al. Greater severity of new onset asthma in allergic subjects who smoke: A 10-year longitudinal study. Respir Res 2011; 12: 16.
25. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008; 63: 132-135.
26. Leuppi JD, Steurer-Stey C, Wildhaber J, et al. Asthma control in Switzerland: A general practitioner based survey. Curr Med Res Opin 2006; 22: 2159-2166.
27. Clatworthy J, Price D, Ryan D, et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009; 18: 300-305.
28. Laforest L, Van Ganse E, Devouassoux G, et al. Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol 2006; 117: 1404-1410.
29. Schatz M, Zeiger RS, VollmerWM, et al.Determinants of future longterm asthma control. J Allergy Clin Immunol 2006; 118: 1048-1053.
30. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-1200.
31. Thomson NC, Spears M. The role of cigarette smoking on persistent airflow obstruction in asthma. Ann Respir Med 2011; 2: 47-54.
32. Jang AS, Park JS, Lee JH, et al. The impact of smoking on clinical and therapeutic effects in asthmatics. J Korean Med Sci 2009; 24: 209-214.
33. Apostol G, Jacobs D, Tsai A, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40. Am J Respir Crit Care Med 2002; 166: 166-172.
34. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton health study: The effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171: 109-114.
35. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: Factors important for the decline in lung function. Thorax 1992; 47: 14-18.
36. Grol MH, Gerritsen J, Vonk JM, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. Am J Respir Crit Care Med 1999; 160: 1830-1837.
37. Spears M, Cameron E, Chaudhuri R, et al. Challenges of treating asthma in people who smoke. Expert Rev Clin Immunol 2010; 6: 257-268.
38. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226-230.
39. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175: 783-790.
40. Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus nonsmokers with mild asthma. Thorax 2005; 60: 282-287.
41. Pedersen B, Dahl R, Karlstrom R, et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med 1996; 153: 1519-1529.
42. Pedersen SE, Bateman ED, Bousquet J, et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 2007; 120: 1036-1042.
43. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168: 1308-1311.
44. Strachan D, Cook D. Parental smoking and childhood asthma: Longitudinal and case-control studies. Thorax 1998; 53: 204-212.
45. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, Centers for Disease Control and Prevention, National Centre for Chronic Disease Prevention, 2006.
46. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: Systematic review and meta-analysis. Pediatrics 2012; 129: 735-744.
47. Accordini S, Janson C, Svanes C, et al. The role of smoking in allergy and asthma: Lessons from the ECRHS. Curr Allergy Asthma Rep 2012; 12: 185-191.
48. Skorge T, Eagan T, Eide G, et al. The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. Am J Respir Crit Care Med 2005; 172: 61-66.
49. Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax 2010; 65: 739-744.
50. Newman RB, Momirova V, Dombrowski MP, et al. The effect of active and passive household cigarette smoke exposure on pregnant women with asthma. Chest 2010; 137: 601-608.
51. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) 2011. www.ginasthma.org Date last accessed: April 2012.
52. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
53. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: Asthma control and exacerbations: Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99.
54. Comhair SAA, Gaston BM, Ricci KS, et al. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One 2011; 6: E18574.
55. Menzies D, Nair A, Williamson P, et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA 2006; 296: 1742-1748.
56. Higenbottam T, Feyeraband C, Clark T. Cigarette smoking in asthma. Br J Dis Chest 1980; 74: 279-284.
57. Jensen E, Dahl R, Steffensen F. Bronchial reactivity to cigarette smoke; relation to lung function, respiratory symptoms, serumimmunoglobulin E and blood eosinophil and leukocyte counts. Resp Med 2000; 94: 119-127.
58. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365: 1184-1192.
59. Chaudhuri R, Livingston E, McMahaon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
60. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: Association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61: 105-110.
61. Lange P, Scharling H et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006; 61: 100-104.
62. O'Byrne PM, Lamm CJ, Busse WW, et al. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009; 136: 1514-1520.
63. Boulet LP, Lemiere C, Archambault F, et al. Smoking and asthma: Clinical and radiologic features, lung function, and airway inflammation. Chest 2006; 129: 661-668.
64. Chalmers GW, Macleod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120: 1917-1922.
65. Stanescu D, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271.
66. Broekema M, ten Hacken NH, Volbeda F, et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009; 180: 1170-1178.
67. Loffek S, Schilling O, Franzke CW. Biological role of matrix metalloproteinases: A critical balance. Eur Respir J 2011; 38: 191-208.
68. Chaudhuri R, McSharry C, Brady J, et al. Sputum MMP-12 in COPD and asthma: Relationship to disease severity. J Allergy Clin Immunol 2012; 129: 655-663.
69. Polosa R, Salvi S, Di Maria GU. Allergic susceptibility associated with diesel exhaust particle exposure: Clear as mud. Arch Environ Health 2002; 57: 188-193.
70. Diaz-Sanchez D, Rumold R, Gong H Jr. Challenge with environmental tobacco smoke exacerbates allergic airway disease in human beings. J Allergy Clin Immunol 2006; 118: 441-446.
71. Floreani AA, Rennard SI. The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med 1999; 5: 38-46.
72. Piccillo G, Caponnetto P, Barton S, et al. Changes in airway hyperresponsiveness following smoking cessation: Comparisons between Mch and AMP. Respir Med 2008; 102: 256-265.
73. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368: 780-793.
74. Cazzola M, Polosa R. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr Opin Allergy Clin Immunol 2006; 6: 43-50.
75. Barnes P. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010; 120: 76-85.
76. Adenuga D, Yao H, March TH, et al. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 2009; 40: 464-473.
77. Livingston E, Darroch CE, Chaudhuri R, et al. Glucocorticoid receptor alpha:beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol 2004; 114: 1475-1478.
78. Adams RJ, Weiss ST, Fuhlbrigge A. How and by whom care is delivered influences anti-inflammatory use in asthma: Results of a national population survey. J Allergy Clin Immunol 2003; 112: 445-450.
79. Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43: 75-80.
80. Invernizzi G, Ruprecht A, De Marco C, et al. Inhaled steroid/tobacco smoke particle interactions: A new light on steroid resistance. Resp Res 2009; 10: 48.
81. Venarske DL, Busse WW, Griffin MR, et al. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 2006; 193: 1536-1543.
82. Svanes C. What has the ECRHS told us about the childhood risk of asthma, allergy and lung function? Clin Respir J 2008; 2: Suppl. 1, 34-44.
83. Tonnesen P, Pisinger C, Hvidberg S, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7: 139-148.
84. Fennerty AG, Banks J, Ebden P, et al. The effect of cigarette withdrawal on asthmatics who smoke. Eur J Respir Dis 1987; 71: 395-399.
85. Eisner MD, Yelin EH, Katz PP, et al. Predictors of cigarette smoking and smoking cessation among adults with asthma. Am J Public Health 2000; 90: 1307-1311.
86. Wakefield M, Ruffin R, Campbell D, et al. Smoking-related beliefs and behaviour among adults with asthma in a representative population sample. Aust NZ J Med 1995; 25: 12-17.
87. Fiore MC, Jaen CR, Baker TB, et al. Clinical practice guidelines: Treating tobacco use and dependence: 2008 update. US Dept of Health and Human Services, Public Health Service, 2008. www. ahrq.gov/clinic/tobacco/treating- tobacco-use08.pdf Date last accessed: April 2012.
88. Polosa R, Benowitz NL. Treatment of nicotine addiction: Present therapeutic options and pipeline developments. Trends Pharmacol Sci 2011; 32: 281-289.
89. Caponnetto P, Polosa R. Common predictors of smoking cessation in clinical practice. Respir Med 2008; 102: 1182-1192.
90. Cummings KM, Giovino G, Jaen CR, et al. Reports of smoking withdrawal symptoms over a 21-day period of abstinence. Addict Behav 1985; 10: 373-381.
91. Caponnetto P, Polosa R, Best D. Tobacco use cessation counseling of parents. Curr Opin Pediatr 2008; 20: 729-733.
92. World Health Organization report on the global tobacco epidemic, 2009; implementing smoke-free environments. Geneva, World Health Organization, 2009. www.who.int/tobacco/mpower/2009/gtcr-download/en/index.html Date last accessed: April 2012.
93. World Health Organization. The European Tobacco Control Report 2007. Geneva, World Health Organization, 2007. www. euro.who.int/-data/assets/pdf- file/0005/68117/E89842.pdf Date last accessed: April 2012.
94. Thomson NC, Spears M. Asthma guidelines and smoking: It's time to be inclusive. Chest 2012; 141: 286-288.
95. Clearie K, McKinlay L, Williamson P, et al. Fluticasone/salmeterol combination confers benefits in smoking asthmatics. Chest 2012; 141: 330-338.
96. Spears M, Donnelly I, Jolly L, et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: A pilot study. Eur Respir J 2009; 33: 1010-1017.
97. Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma. Resp Med 2008; 102: 50-56.
98. van Schayck OCP, Haughney J, Aubier M, et al. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. Respir Med 2012; 106: 189-196.
99. Etter JF, Lukas RJ, Benowitz NL, et al. Cytisine for smoking cessation: A research. Drug Alcohol Depend 2008; 92: 3-8.
100. Maurer P, Bachmann MF. Vaccination against nicotine: An emerging therapy for tobacco dependence. Expert Opin Investig Drugs 2007; 16: 1775-1783.
101. Xenova Group PLC. News release. Anti-smoking vaccine TANIC preliminary 12 month clinical trial. March 2005. http://hugin.info/133161/R/982993/146255.pdf Date last accessed: April 2012.
102. Hatsukami DK, Rennard S, Jorenby D, et al. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clin Pharmacol Ther 2005; 78: 456-467.
103. Ito K, Caramori G, Adcock IM. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther 2007; 321: 1-8.
104. Marwick JA, Caramori G, Stevenson CS, et al. Inhibition of pi3kd restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Cri Care Med 2009; 179: 542-548.
105. Brehm JM, Celedon JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in costa rica. Am J Respir Crit Care Med 2009; 179: 765-771.
106. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006; 116: 146-155.
107. Spears M, McSharry C, Thomson NC. Peroxisome proliferatoractivated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 2006; 36: 1494-1504.
108. Spears M, Donnelly I, Jolly L, et al. Bronchodilatory effect of the PPAR-c agonist rosiglitazone in smokers with asthma. Clin Pharmacol Ther 2009; 86: 49-53.
109. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax 2006; 61: 729-734.
110. Braganza G, Chaudhuri R, McSharry C, et al. Effects of shortterm treatment with atorvastatin in smokers with asthma-A randomized controlled trial. BMC Pulm Med 2011; 11: 16.
111. Hothersall EJ, Chaudhuri R, McSharry C, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008; 63: 1070-1075.
112. Cameron EJ, Chaudhuri R, McSharry C, et al. Effects of azithromycin on asthma control, airway inflammation and bacterial colonization in smokers with asthma-a randomized controlled trial. Am J Respir Crit Care Med 2012; 185: A3965.
113. Zheng J-P, Kang J, Huang S-G, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE study): A randomised placebo-controlled study. Lancet 2008; 371: 2013-2018.